SanofiSNY

Where SNY's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$43.16-1.08 (-2.44%)Previous close
NASDAQHealthcare

SNY Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
SNY Net Debt / EBITDA historySNY Net Debt / EBITDA from Sep 2023 to Jun 2026: low 0.55, high 2.09, latest 1.39.0.430.881.321.772.22Sep 23Mar 24Dec 24Jun 25Dec 25Jun 26med 1.15

SNY Net Debt / EBITDA by year

Yearly range of SNY’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.5 to 3.3, averaging 1.3.

SNY Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.11.31.41.4
20250.71.11.41.0
20241.01.42.11.2
20230.60.91.01.0
20220.60.91.40.6
20210.81.01.31.3
20200.51.01.60.5
20191.02.13.33.0
20181.02.13.12.5
20170.81.01.30.9
20160.90.91.01.0

Get notified when SNY Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.